Literature DB >> 21562249

Amyotrophic lateral sclerosis and spinocerebellar ataxia 2.

Kenneth H Fischbeck, Stefan M Pulst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21562249     DOI： 10.1212/WNL.0b013e31821f4498

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  RNA-binding proteins with prion-like domains in ALS and FTLD-U.

Authors:  Aaron D Gitler; James Shorter
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

2.  ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.

Authors:  Michael P Hart; Aaron D Gitler
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

3.  Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.

Authors:  Michael P Hart; Johannes Brettschneider; Virginia M Y Lee; John Q Trojanowski; Aaron D Gitler
Journal:  Acta Neuropathol       Date:  2012-04-21       Impact factor: 17.088

4.  Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis.

Authors:  Matthew D Figley; Anna Thomas; Aaron D Gitler
Journal:  Neurobiol Aging       Date:  2013-10-23       Impact factor: 4.673

5.  The RNA-binding protein ATX-2 regulates cytokinesis through PAR-5 and ZEN-4.

Authors:  Megan M Gnazzo; Eva-Maria E Uhlemann; Alex R Villarreal; Masaki Shirayama; Eddie G Dominguez; Ahna R Skop
Journal:  Mol Biol Cell       Date:  2016-08-24       Impact factor: 4.138

Review 6.  ALS Yeast Models-Past Success Stories and New Opportunities.

Authors:  Sonja E Di Gregorio; Martin L Duennwald
Journal:  Front Mol Neurosci       Date:  2018-10-30       Impact factor: 5.639

7.  De novo mutations in ataxin-2 gene and ALS risk.

Authors:  José Miguel Laffita-Mesa; Jorge Michel Rodríguez Pupo; Raciel Moreno Sera; Yaimee Vázquez Mojena; Vivian Kourí; Leonides Laguna-Salvia; Michael Martínez-Godales; José A Valdevila Figueira; Peter O Bauer; Roberto Rodríguez-Labrada; Yanetza González Zaldívar; Martin Paucar; Per Svenningsson; Luís Velázquez Pérez
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

8.  Yeast genetic screen reveals novel therapeutic strategy for ALS.

Authors:  Matthew D Figley; Aaron D Gitler
Journal:  Rare Dis       Date:  2013-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.